Verus Capital Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
1,586
-635
-29% -$112K 0.01% 458
2026
Q1
$399K Buy
2,221
+152
+7% +$26K 0.03% 312
2025
Q4
$293K Buy
+2,069
New +$235K 0.02% 359
2024
Q4
– Sell
-2,685
Closed -$254K – 368
2024
Q3
$254K Buy
2,685
+499
+23% +$44.3K 0.02% 299
2024
Q2
$209K Sell
2,186
-134
-6% -$15.9K 0.02% 321
2024
Q1
$306K Buy
2,320
+420
+22% +$51.7K 0.03% 262
2023
Q4
$275K Buy
1,900
+545
+40% +$74.8K 0.03% 246
2023
Q3
$230K Buy
+1,355
New +$270K 0.03% 260
2020
Q1
$68K Sell
1,215
-371
-23% -$28.4K 0.02% 402
2019
Q4
$116K Buy
+1,586
New +$106K 0.04% 340

Other funds holding ALB

Verus Capital Partners's ALB Position: Q2 2026 in Review

Verus Capital Partners reduced its Albemarle (ALB) stake by 29% in Q2 2026, selling an estimated $112K and leaving 1,586 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #458.

Verus Capital Partners first reported a position in ALB in Q4 2019 and has held it in 10 quarters since. The position peaked at $399K in Q1 2026. 945 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Verus Capital Partners held 1,586 shares of Albemarle worth $214K as of Q2 2026.
  • Verus Capital Partners sold 635 Albemarle shares in Q2 2026, an estimated $112K.
  • Albemarle made up 0.01% of Verus Capital Partners's portfolio in Q2 2026, its #458 holding.
  • Verus Capital Partners first reported a position in Albemarle in Q4 2019 and has held it in 10 quarters since.
  • Verus Capital Partners's Albemarle position peaked at $399K in Q1 2026.
  • 945 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.